# FDA Inspection 1268116 - Guangxi Yulin Pharmaceutical Group Co. Ltd. - March 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/82a89afe-506e-4e84-9dd2-02a225853a04
Source feed: FDA_Inspections

> FDA Inspection 1268116 for Guangxi Yulin Pharmaceutical Group Co. Ltd. on March 21, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268116
- Company Name: Guangxi Yulin Pharmaceutical Group Co. Ltd.
- Inspection Date: 2025-03-21
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 992915 - 2016-09-29](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/3234756c-c4c4-4f85-9e17-82bfde214835)
- [FDA Inspection 992915 - 2016-09-29](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/53547aca-4a56-4e32-a161-c8403b574891)
- [FDA Inspection 748465 - 2011-09-22](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/3b262c58-6d65-429e-affe-36929fbbb2e4)

Company: https://www.keypedia.com/companies/guangxi-yulin-pharmaceutical-group-co-ltd/3815cb2a-39f8-4338-9e21-e6dcd7f7a015

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8